Cellomics, Inc. Offers Customers Expanded HCS Training

PITTSBURGH, Sept. 14, 2006—Cellomics, the creator of and world leader in high content screening (HCS) and a unit of Fisher Biosciences, has expanded its continuing education curriculum with the introduction of advanced courses in HCS applications. These courses will offer customers training for specific uses in biology research and therapeutics, including such fields as oncology, neurobiology and toxicology.